Concord Wealth Partners’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-95	Closed	-$18.7K	–	936
2024 Q3	$18.7K	Buy	+95	New	+$19.7K	﹤0.01%	480
2024 Q2	–	Sell	-259	Closed	-$70.2K	–	857
2024 Q1	$70.2K	Buy	259 +203	+363%	+$48.5K	0.01%	310
2023 Q4	$13.2K	Sell	56 -195	-78%	-$38.3K	﹤0.01%	535
2023 Q3	$49.2K	Hold	251	–	–	0.01%	381
2023 Q2	$52.8K	Buy	251 +102	+68%	+$20.3K	0.01%	360
2023 Q1	$30.1K	Sell	149 -1	-0.7%	-$227	0.01%	423
2022 Q4	$32.7K	Buy	+150	New	+$32.8K	0.01%	455
2022 Q3	–	Sell	-150	Closed	-$32K	–	347
2022 Q2	$32K	Sell	150 -37	-20%	-$9.04K	0.01%	443
2022 Q1	$53K	Sell	187 -5	-3%	-$1.54K	0.01%	422
2021 Q4	$72K	Buy	192 +184	+2,300%	+$71.5K	0.02%	371
2021 Q3	$3K	Sell	8 -9	-53%	-$3.74K	﹤0.01%	673
2021 Q2	$6K	Hold	17	–	–	﹤0.01%	703
2021 Q1	$5K	Buy	17 +13	+325%	+$3.61K	﹤0.01%	660
2020 Q4	$1K	Buy	+4	New	+$953	﹤0.01%	607